Survey reveals missed chances for HIV prevention
NCT ID NCT03671291
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study surveyed 596 people in France who were newly diagnosed with HIV. The goal was to find out why they did not use pre-exposure prophylaxis (PrEP), a medicine that prevents HIV infection. By understanding these missed opportunities, researchers hope to improve how PrEP is offered and used.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIRUS-HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre d'Informations et de soins de l'Immunodéficience Humaine et des hépatites Virales- CHU Sainte-Marguerite
Marseille, 13009, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.